Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.55 USD | -2.45% | -14.01% | -10.55% |
Apr. 02 | Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer | CI |
Apr. 02 | Voyager Therapeutics, Inc. Announces CFO Changes | CI |
Evolution of the average Target Price on Voyager Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Voyager Therapeutics, Inc.
Guggenheim | |
HC Wainwright | |
Citigroup | |
Wedbush | |
Truist Securities | |
Oppenheimer | |
Chardan Research | |
Chardan | |
Baird | |
BTIG |
EPS Revisions
- Stock Market
- Equities
- VYGR Stock
- Consensus Voyager Therapeutics, Inc.